BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 26016536)

  • 1. Cutaneous plasmacytosis: a clinicopathologic study of 12 cases in Taiwan revealing heterogeneous underlying causes.
    Lu PH; Shih LY; Yang CH; Kuo TT
    Int J Dermatol; 2015 Oct; 54(10):1132-7. PubMed ID: 26016536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High ratio of IgG4-positive plasma cell infiltration in cutaneous plasmacytosis--is this a cutaneous manifestation of IgG4-related disease?
    Miyagawa-Hayashino A; Matsumura Y; Kawakami F; Asada H; Tanioka M; Yoshizawa A; Mikami Y; Kotani H; Nakashima Y; Miyachi Y; Manabe T
    Hum Pathol; 2009 Sep; 40(9):1269-77. PubMed ID: 19386351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cutaneous involvement in multiple myeloma: a clinicopathologic, immunohistochemical, and cytogenetic study of 8 cases.
    Requena L; Kutzner H; Palmedo G; Calonje E; Requena C; PĂ©rez G; Pastor MA; Sangueza OP
    Arch Dermatol; 2003 Apr; 139(4):475-86. PubMed ID: 12707095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cutaneous plasmacytosis: A report of five cases with immunohistochemical evaluation for HHV-8 expression.
    Jayaraman AG; Cesca C; Kohler S
    Am J Dermatopathol; 2006 Apr; 28(2):93-8. PubMed ID: 16625068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of Cutaneous Plasmacytosis at Different Disease Stages.
    Hsiao PF; Wu YH
    Dermatology; 2016; 232(6):738-747. PubMed ID: 28222449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The cut-offs for kappa/lambda ratio in bone marrow immunohistochemistry for the diagnosis of multiple myeloma.
    Warnnissorn AN; Treetipsatit J; Limvorapitak W
    Hematology; 2020 Dec; 25(1):292-298. PubMed ID: 32772824
    [No Abstract]   [Full Text] [Related]  

  • 7. Metastatic cutaneous plasmacytoma: a case report associated with IgA lambda multiple myeloma and a review of the literature of metastatic cutaneous plasmacytomas associated with multiple myeloma and primary cutaneous plasmacytomas.
    Kato N; Kimura K; Yasukawa K; Aikawa K
    J Dermatol; 1999 Sep; 26(9):587-94. PubMed ID: 10535253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cutaneous plasmacytosis: report of 6 cases with or without systemic involvement.
    Honda R; Cerroni L; Tanikawa A; Ebihara T; Amagai M; Ishiko A
    J Am Acad Dermatol; 2013 Jun; 68(6):978-85. PubMed ID: 23360866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Specific cutaneous involvement in patients with multiple myeloma. A clinicopathological, immunohistochemical and cytogenetic study of 40 cases].
    Requena L
    Actas Dermosifiliogr; 2005 Sep; 96(7):424-40. PubMed ID: 16476270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of IgG4+ Plasma Cell Infiltration in Patients with Systemic Plasmacytosis and Other Plasma Cell-infiltrating Skin Diseases.
    Takeoka S; Kamata M; Hau CS; Tateishi M; Fukaya S; Hayashi K; Fukuyasu A; Tanaka T; Ishikawa T; Ohnishi T; Sasajima Y; Watanabe S; Tada Y
    Acta Derm Venereol; 2018 Apr; 98(5):506-511. PubMed ID: 29437186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IgG subclass distribution in patients with multiple myeloma or with monoclonal gammopathy of undetermined significance.
    Papadea C; Reimer CB; Check IJ
    Ann Clin Lab Sci; 1989; 19(1):27-37. PubMed ID: 2492788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoperoxidase staining of bone marrow sections.
    Hitzman JL; Li CY; Kyle RA
    Cancer; 1981 Dec; 48(11):2438-46. PubMed ID: 6794902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunopathological diagnosis of plasma-cell dyscrasia. Part I. "Primary" monoclonal gammopathy.
    Huang TS; Tien HF; How SW; Chuang CY; Sohail AB
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1983 May; 16(2):84-91. PubMed ID: 6413168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extensive hyperpigmented plaques in a chinese singaporean woman: a case of cutaneous plasmacytosis.
    Lee JS; Chiam L; Tan KB; Salto-Tellez M; Tan SH; Ong BH; Ng SK
    Am J Dermatopathol; 2011 Jul; 33(5):498-503. PubMed ID: 21242755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IgG4-positive cells in skin lesions of cutaneous and systemic plasmacytosis.
    Kato K; Satoh T; Tanaka-Fujimoto T; Ueda N; Yokozeki H
    Eur J Dermatol; 2013 Apr; 23(2):255-6. PubMed ID: 23587770
    [No Abstract]   [Full Text] [Related]  

  • 16. Detection of clonality with kappa and lambda immunohistochemical analysis in cutaneous plasmacytomas.
    Bayer-Garner IB; Prieto VG; Smoller BR
    Arch Pathol Lab Med; 2004 Jun; 128(6):645-8. PubMed ID: 15163236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cutaneous plasmacytosis: A rare entity with unique presentation.
    Dhar S; Liani L; Patole K; Dhar S
    Indian J Dermatol Venereol Leprol; 2017; 83(6):673-676. PubMed ID: 28799534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multicentric Castleman disease with cutaneous manifestations: report of 2 cases and comparison with systemic plasmacytosis.
    Higashi Y; Kanekura T; Sakamoto R; Mochitomi Y; Kanzaki T
    Dermatology; 2007; 214(2):170-3. PubMed ID: 17341868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and clinicopathologic characteristics of multiple myeloma with cutaneous involvement: A case series from Korea.
    Woo YR; Kim JS; Lim JH; Hwang S; Kim M; Bae JM; Park YM; Min CK; Kim DW; Park HJ
    J Am Acad Dermatol; 2018 Mar; 78(3):471-478.e4. PubMed ID: 29107338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased numbers of IgG4-positive plasma cells may rarely be seen in lymph nodes of patients without IgG4-related sclerosing disease.
    Rollins-Raval MA; Felgar RE; Krasinskas AM; Roth CG
    Int J Surg Pathol; 2012 Feb; 20(1):47-53. PubMed ID: 21911432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.